肾交感神经阻断术设备市场：依手术类型、最终用户、地区

2023年，全球肾交感神经阻断术装置市场规模为9.039亿美元，预计2030年将达到23.321亿美元，2023年至2030年的复合年增长率为14.5%。

图 1.肾交感神经阻断术装置的全球市场占有率(%)（按地区），2023 年

肾交感神经阻断术是一种微创手术，旨在减少肾臟的交感神经活动。导管穿过动脉直至到达肾动脉，肾动脉供应肾臟血液。然后它向血管壁中的神经提供能量，以破坏导致高血压的信号。能量可以透过多种方式传递，包括射频消融术、超音波以及最近基于直接注射化学品和经皮传递系统的新技术。肾交感神经阻断术的基本原则源自于对肾臟在调节血压中扮演重要角色的认知。肾神经的过度活化导致全身血压升高。透过阻断这些过度活跃的神经途径，肾交感神经阻断术可能有助于持续降低其他治疗方法无效的患者的血压。儘管这种治疗方法在早期临床试验中显示出了希望，但随后的几项临床试验却得出了不同的结果。儘管如此，这种医疗设备仍在继续研究和开发，目前正在进行临床试验以评估其安全性和有效性。

市场动态：

预计去肾交感神经阻断术装置市场在预测期内（2023-2030年）将显着成长。有几个因素促进了市场的成长，包括高血压盛行率的上升。此外，创新产品的核准增加预计也将在预测期内推动市场成长。例如，医疗设备公司 Kalos Medical 获得了 467 万韩元（约 350 万美元）的津贴，用于推进治疗高血压的去肾交感神经阻断术医疗设备的开发。

本研究的主要特点

• 这份研究报告对全球肾交感神经阻断术装置市场进行了详细分析，包括市场规模（单位：百万美国）、以2022年为基准年的预测期（2023-2030年）的复合年增长率等。
• 它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 根据公司亮点、产品系列、主要亮点、业绩和策略等参数对全球肾交感神经阻断术设备市场的主要企业进行了介绍。
• 本研究涵盖的主要企业包括美敦力 (Medtronic)、Recor Medical、波士顿科学公司 (Boston Scientific Corp)、科纳医疗 (Kona Medical)、泰尔茂公司 (Terumo Corporation)、雅培 (Abbott) 和 Ablative Solutions。
• 该报告的见解将使公司行销人员和负责人能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
• 全球肾交感神经阻断术设备市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球肾交感神经阻断术设备市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 急性腔室症候群盛行率增加
• 技术进步
  • 抑制因素
• 复杂的法律规范
  • 机会
• 新兴经济体尚未开发的潜力
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章全球肾交感神经阻断术设备市场－冠状病毒 (COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球肾交感神经阻断术设备市场，依手术类型，2018-2030

• 经皮肾经皮肾交感神经阻断术
• 射频肾交感神经阻断术
• 超音波肾交感神经阻断术
• 其他的

第六章全球肾交感神经阻断术设备市场，依最终使用者划分，2018-2030 年

• 医院
• 诊所
• 门诊手术中心
• 其他的

第七章全球肾交感神经阻断术设备市场，依地区，2018-2030

• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• ASEAN
• 韩国
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• GCC
• 以色列
• 其他中东地区
• 非洲
• 南非
• 中部非洲
• 北非

第八章 竞争形势

• Medtronic
• Recor Medical, Inc.
• Boston Scientific Corp
• Kona Medical
• Terumo Corporation
• Abbott
• Ablative Solutions
• 其他的

第9章 章节

• 调查方法
• 关于出版商

The global renal denervation devices market size was valued at US$ 903.9 million in 2023 and is expected to reach US$ 2,332.1 million by 2030, at a CAGR of 14.5% from 2023 to 2030.

Figure 1. Global Renal Denervation Devices Market Share (%), by Region, 2023

Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.

Market Dynamics:

The renal denervation devices market is expected to witness significant growth during the forecast period (2023-2030). Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.

Key Features of the Study:

• This report provides an in-depth analysis of the global renal denervation devices market, including market size (in US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key players in the global renal denervation devices market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies
• Key companies covered in this study include Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions, and others
• Insights from this report would enable marketers and management authorities of companies to make informed decisions regarding future product launches, product upgrades, market expansion, and marketing tactics.
• The global renal denervation devices market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global renal denervation devices market

Renal Denervation Devices Market Segmentation

• By Procedure Type
  • Percutaneous Renal Denervation
  • Radiofrequency Renal Denervation
  • Ultrasound Renal Denervation
  • Others
• By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Top Companies in the Renal Denervation Devices Market
  • Medtronic
  • Recor Medical, Inc
  • Boston Scientific Corp
  • Kona Medical
  • Terumo Corporation
  • Abbott
  • Ablative Solutions
  • Others

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Procedure Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of acute compartment syndrome
• Technological Advancement
  • Restraints
• Complex Regulatory Framework
  • Opportunities
• Untapped Potential in the Emerging Economies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Renal Denervation Devices Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Renal Denervation Devices Market , By Procedure Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Percutaneous Renal Denervation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Radiofrequency Renal Denervation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Ultrasound Renal Denervation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Renal Denervation Devices Market , By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Global Renal Denervation Devices Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2018 - 2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• China
• Japan
• India
• Australia
• ASEAN
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030,(US$ Mn)
• South Africa
• Central Africa
• North Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Recor Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boston Scientific Corp
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Kona Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ablative Solutions
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Others
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us